SUR-2, also known as sulfonylurea receptor 2, is an integral component of ATP-sensitive potassium (KATP) channels, which are crucial regulators of cellular excitability and insulin secretion in pancreatic beta cells and other excitable tissues. Functionally, SUR-2 acts as a regulatory subunit of KATP channels, modulating their sensitivity to intracellular ATP and ADP levels. KATP channels consist of inwardly rectifying potassium channel subunits (Kir6.x) and regulatory SUR subunits, forming hetero-octameric complexes that reside in the plasma membrane. Under physiological conditions, high intracellular ATP concentrations inhibit KATP channel activity by binding to SUR-2, promoting channel closure and membrane depolarization. Conversely, decreased ATP levels or increased ADP levels relieve this inhibition, leading to KATP channel opening, potassium efflux, and membrane hyperpolarization, which inhibit cellular excitability and promote insulin release in pancreatic beta cells. Beyond its role in pancreatic beta cells, SUR-2-mediated KATP channel regulation also influences cardiovascular function, smooth muscle tone, and neuronal excitability, highlighting its importance in diverse physiological processes.
Activation of SUR-2 is governed by multiple regulatory mechanisms that modulate its interaction with nucleotides, drugs, and regulatory proteins. Binding of intracellular ATP to SUR-2 induces conformational changes that stabilize the closed state of KATP channels, inhibiting potassium efflux and maintaining cellular quiescence. Conversely, nucleotide binding to the nucleotide-binding domains (NBDs) of SUR-2 can trigger channel opening in response to metabolic stress or pharmacological agents such as sulfonylurea drugs. Moreover, post-translational modifications, including phosphorylation and palmitoylation, regulate SUR-2 activity and subcellular localization, influencing KATP channel function and cellular excitability. The dynamic interplay between these regulatory mechanisms ensures precise control over KATP channel activity in response to metabolic and pharmacological cues, contributing to the maintenance of cellular homeostasis and physiological function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, raising cAMP levels, which can lead to the activation of PKA and potentially increase SUR-2 transcription. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC which could enhance transcription factors that increase SUR-2 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Affects gene expression and could enhance SUR-2 expression through retinoic acid receptor-mediated transcriptional activation. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
As a hormone, it can modulate gene expression and potentially upregulate SUR-2 through estrogen receptor-mediated signaling. | ||||||
L-3,3′,5-Triiodothyronine, free acid | 6893-02-3 | sc-204035 sc-204035A sc-204035B | 10 mg 100 mg 250 mg | $41.00 $77.00 $153.00 | ||
L-3,3′,5-Triiodothyronine, free acid modulates gene expression and might upregulate SUR-2 through thyroid hormone receptor-mediated transcriptional activation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences multiple signaling pathways and could increase SUR-2 expression through Wnt pathway activation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor that can lead to a more open chromatin state and potentially increase transcription of SUR-2. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Another histone deacetylase inhibitor that could indirectly increase SUR-2 expression by affecting chromatin accessibility. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Regulates gene expression and might enhance SUR-2 expression through vitamin D receptor-mediated transcriptional activation. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid that can regulate gene expression, potentially increasing SUR-2 transcription through glucocorticoid receptor activation. | ||||||